SERS Screening Kit for Cervical Cancer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cervical cancer screening methods, such as the Pap smear test, require trained cytotechnologists and are not feasible in resource-constrained settings like India, where there is a high burden of cervical cancer due to the lack of skilled personnel and the need for cost-effective alternatives.
Innovation Solution
A SERS-based screening kit using gold nanoparticles (AuNPs) for label-free analysis of exfoliated cervical cells, which enhances Raman signals and reduces autofluorescence, allowing for the differentiation of normal, high-grade squamous intraepithelial lesions, and cervical squamous cell carcinoma through distinct Raman spectral patterns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If Pap smear test with microscopic analysis is used for cervical cancer screening, then detection accuracy is improved, but requirement for highly trained cytotechnologists increases and cost increases
Solution Approach 1:
The patent replaces the mechanical/microscopic analysis system requiring trained cytotechnologists with a Raman spectroscopy-based chemical fingerprinting system. The SERS substrate enables detection of biochemical signatures of precancerous lesions through molecular vibrations, substituting human expert visual analysis with automated spectral analysis that does not require specialized training.
Solution Approach 2:
The invention shifts from analyzing morphological parameters (cell shape, size, structure) under microscope to analyzing biochemical parameters (molecular vibrations, spectral fingerprints) through Raman spectroscopy. This parameter transformation enables automated detection algorithms to identify precancerous changes based on chemical composition rather than requiring trained eyes to interpret cellular morphology.
2Loss of information
If conventional Raman spectroscopy is used for cancer detection, then biochemical information is obtained, but signal intensity is weak and fluorescence background is strong
Solution Approach 1:
The patent introduces a SERS substrate (metallic nanostructure) as an intermediary between the laser excitation and the molecular samples. This substrate mediates the interaction by providing localized surface plasmon resonance that amplifies the Raman scattering signal from molecules adsorbed on or near the substrate surface, thereby enhancing the already weak Raman signal by several orders of magnitude.
Solution Approach 2:
The invention employs composite material systems combining metallic nanoparticles with specific surface chemistries to create SERS-active substrates. These composite structures provide both the electromagnetic field enhancement needed for signal amplification and the chemical functionality for selective molecular binding, simultaneously addressing signal intensity and biochemical specificity requirements.
3Ease of operation
If automated screening method is developed to reduce need for trained personnel, then ease of operation is improved, but detection precision may be compromised
Solution Approach 1:
The patent creates a spectral fingerprint copy of the biochemical signature present in cervical cells. Instead of requiring direct visual interpretation of complex cellular images, the system generates simplified Raman spectral profiles that serve as unique biochemical identifiers for normal versus precancerous cells. These spectral copies can be stored in databases and compared automatically, enabling automated detection with high accuracy without requiring trained personnel to interpret raw data.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The kit provides a reliable, non-invasive, and cost-effective method for cervical cancer screening with high sensitivity and specificity, demonstrated by significant spectral differences and accurate prediction accuracy using chemometric analysis, potentially reducing the reliance on skilled personnel and improving early detection rates.
Implementation Method 1
Raman spectroscopy recently has emerged as a novel non-invasive diagnostic tool for cancer detection and identification of malignancy at different stages of neoplasia in tissues
Implementation Method 2
Surface enhanced Raman scattering (SERS) technology greatly improves the detection sensitivity of Raman spectroscopy
Data Source
AI summary
The capabilities of using gold nanoparticle as surface-enhanced Raman scattering (SERS) substrate to obtain cervical smear harvested cells biochemical information for non-invasive cervical precancerous detection were presented in this patent document. A SERS reagent and a platform has been developed and optimized for the generation of a differential spectral fingerprinting for cervical cancer detection. SERS measurements were performed on three group's cervical exfoliated cell samples: one group from patients (n=36) with pathologically confirmed cervical cancer and another group with high-grade squamous intraepithelial lesion (HSIL) (n=41) and the last group from healthy volunteers (control subjects, n=47). Tentative assignments of the Raman bands in the measured SERS spectra suggested interesting cancer specific biomolecular changes, including an increase in the relative amounts of amino acids, nucleic acid, carotenoid contents in the cell samples of cervical cancer patients as compared to that of healthy subjects. The results from this study demonstrated that gold nanoparticle based SERS substrate harvested exfoliated cervical smear cell analysis has tremendous potential for the non-invasive detection of cervical precancerous lesions.